Aligos Therapeutics Financial Overview
Aligos Therapeutics's market cap is currently $65.72M. The company's EPS TTM is $-3.04; its P/E ratio is -0.54; Aligos Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-2.33. See an overview of income statement, balance sheet, and cash flow financials.
